สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostatske neoplazme - endokrinska terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

มอนเตเนโกร - โครเอเชีย - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"evropa lek pharma" doo podgorica - traneksaminska kiselina - rastvor za injekciju - 500mg/5ml

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

norbrook laboratories (ireland) limited - mcloksikam - anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats; cattle; pigs - dogsalleviation upale i bolova u akutni i kronični mišićno-koštanog sustava. smanjiti postoperativnu bol i upalu nakon operacije ortopedskih i mekih tkiva. catsalleviation upale i bolova u kroničnim poremećajima lokomotornog aparata kod mačaka. da bi se smanjila sobu za intenzivnu njegu bol nakon овариогистерэктомии i male mekih tkiva kirurgija. cattlefor koristiti i kod akutne infekcije respiratornog odgovarajuće antibiotske terapije za smanjenje kliničkih znakova u goveda. za upotrebu u proljevu u kombinaciji s oralnom rehidracijskom terapijom kako bi se smanjili klinički znakovi u teladi starijoj od jednog tjedna i mlade, ne-laktirajuće stoke. za pomoćnu terapiju u liječenju akutnog mastitisa, u kombinaciji s antibiotskom terapijom. koristiti pigsfor u неинфекционной bolestima mišićno-koštanog sustava za ublažavanje simptoma hromost i upale. za pomoćnu terapiju u liječenju puerperalne septikemije i toksemije (mastitis-metritis-agalaktia sindrom) s odgovarajućom terapijom antibioticima. horsesfor koristiti za smanjenje upale i ublažavanje boli u akutni i kronični mišićno-koštanog sustava. za olakšanje boli povezane s kolikom kolica.

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

clinres farmacija d.o.o. - traneksaminska kiselina - otopina za injekciju - 100 mg/1 ml - 1 ampula otopine za injekciju od 5 ml sadrži: 500 mg traneksaminske kiseline

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - antigeni virusa influence (hemaglutinin i neuraminidaza) soja a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cjepiva - aktivna imunizacija protiv h5n1 podtipa virusa gripe a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - nadroparinkalcij - otopina za injekciju u napunjenoj štrcaljki - 2850 iu anti-xa/0,3 ml - urbroj: 0,3 ml otopine za injekciju (1 napunjena štrcaljka) sadrži 2850 iu aktivnosti anti-xa nadroparinkalcija

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - nadroparinkalcij - otopina za injekciju u napunjenoj štrcaljki - 3800 iu anti-xa/0,4 ml - urbroj: 0,4 ml otopine za injekciju (1 napunjena štrcaljka) sadrži 3800 iu aktivnosti anti-xa nadroparinkalcija

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - nadroparinkalcij - otopina za injekciju u napunjenoj štrcaljki - 5700 iu anti-xa/0,6 ml - urbroj: 0,6 ml otopine za injekciju (1 napunjena štrcaljka) sadrži 5700 iu aktivnosti anti-xa nadroparinkalcija

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - nadroparinkalcij - otopina za injekciju u napunjenoj štrcaljki - 7600 iu anti-xa/0,8 ml - urbroj: 0,8 ml otopine za injekciju (1 napunjena štrcaljka) sadrži 7600 iu aktivnosti anti-xa nadroparinkalcija